Home LiteratureArticle Details
PMID: 9029089 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Regulation of CD28 costimulation in human CD8+ T cells.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 158 ·No. 4 ·1997-02-15 ·Pages 1551-8

Lloyd TE, Yang L, Tang DN, Bennett T, Schober W, Lewis DE

Abstract

Optimal stimulation and prevention of anergy in T cells requires signaling through the CD28 molecule. During HIV disease progression, CD28 expression is lost, particularly on CD8+ T cells. Because alterations in cytokine production patterns occur during HIV infection, we determined whether CD8+ T cell phenotype or function was affected by cytokine environment. Treatment of CD8+ T cells with IL-4 decreased levels of both CD28 surface expression and message and increased CD8 expression. Furthermore, CD8+ T cells that had down-regulated CD28 had reduced proliferative capacity. The inhibitory effects of CD28 reduction could be compensated either by increased anti-CD3 or by exogenous IL-2, suggesting that the strength of T cell signaling necessary for the production of IL-2 and subsequent proliferation is negatively regulated by IL-4. CD8+ subpopulations with differential CD28 expression produced different patterns of cytokines, particularly IL-2 and IFN-gamma. Furthermore, CD8+ T cells that had reduced CD28 levels but made their own IL-2 were able to proliferate in response to TCR stimulation. These results suggest that loss of CD28 expression and CD8 T cell function can be regulated by the cytokine environment, which may be altered during HIV disease progression. Whether the dysfunction of CD8+ T cells in HIV infection occurs by such a mechanism is the subject of future investigation.

MeSH Terms
Antibodies, Monoclonal/pharmacology CD28 Antigens/biosynthesis,genetics,physiology CD3 Complex/immunology CD8 Antigens/biosynthesis,drug effects CD8-Positive T-Lymphocytes/immunology,metabolism Cells, Cultured Cytokines/biosynthesis,pharmacology Down-Regulation/immunology Humans Interleukin-2/pharmacology Interleukin-4/pharmacology Lymphocyte Activation RNA, Messenger/biosynthesis T-Lymphocyte Subsets/immunology,metabolism
Chemicals
Antibodies, Monoclonal CD28 Antigens CD3 Complex CD8 Antigens Cytokines Interleukin-2 RNA, Messenger Interleukin-4
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Lloyd T E
Department of Microbiology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.
Yang L
Tang D N
Bennett T
Schober W
Lewis D E
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1997-02-15
Pages
1551-8
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI36211 · United States
NIAID NIH HHS · AI36682 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com